Patents by Inventor Karl Syson

Karl Syson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for determining chemotherapeutic agents targeting alpha-glucan pathways and uses thereof
    Patent number: 8455214
    Abstract: The present invention provides methods for determining a putative antibacterial, the methods comprising determining whether the putative antibacterial inhibits GlgE or Rv3032. The present invention also provides the antibacterial, the pharmaceutical composition and the method of making the antibacterial as well as a method of treating a subject infected with a bacterial comprising administration of the antibacterial.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: June 4, 2013
    Assignees: Albert Einstein College of Medicine of Yeshiva University, Plant Bioscience Limited
    Inventors: William R. Jacobs, Jr., Rainer Kalscheuer, Stephen Bornemann, Karl Syson
  • Methods for determining chemotherapeutic agents targeting alpha-glucan pathways and uses thereof
    Publication number: 20110124593
    Abstract: The present invention provides methods for determining a putative antibacterial, the methods comprising determining whether the putative antibacterial inhibits GlgE or Rv3032. The present invention also provides the antibacterial, the pharmaceutical composition and the method of making the antibacterial as well as a method of treating a subject infected with a bacterial comprising administration of the antibacterial.
    Type: Application
    Filed: October 26, 2010
    Publication date: May 26, 2011
    Inventors: William R. Jacobs, JR., Rainer Kalscheuer, Stephen Bornemann, Karl Syson